相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of AhR in transcriptional regulation of immune cell development and function
Prashant Trikha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S. Trebeschi et al.
ANNALS OF ONCOLOGY (2019)
Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI
Bridget A. Kennis et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series
Martin Benesch et al.
ONCOLOGIST (2019)
Cellular therapy: Immune-related complications
Joseph H. Oved et al.
IMMUNOLOGICAL REVIEWS (2019)
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Dean A. Lee
IMMUNOLOGICAL REVIEWS (2019)
MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma
M. Iv et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2019)
Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma
Andrew M. Heitzer et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response
Ashley S. Plant et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Diagnostic accuracy of MRI texture analysis for grading gliomas
Austin Ditmer et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
TGFβ Imprinting During Activation Promotes Natural Killer Cell Cytokine Hypersecretion
Jennifer A. Foltz et al.
CANCERS (2018)
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA (2017)
Pseudoprogression after glioma therapy: an update
Norbert Galldiks et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Medulloblastoma: From Myth to Molecular
Vijay Ramaswamy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Pseudoprogression after glioma therapy: an update
Norbert Galldiks et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Natural killer cells in malignant hematology: A primer for the non-immunologist
Geoffrey S. Kannan et al.
BLOOD REVIEWS (2017)
Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note
David I. Sandberg et al.
CHILDS NERVOUS SYSTEM (2016)
Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma
Bree R. Eaton et al.
NEURO-ONCOLOGY (2016)
Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment
Justine V. Cohen et al.
CANCER IMMUNOLOGY RESEARCH (2016)
NKG2D ligand expression in pediatric brain tumors
Kristen Haberthur et al.
CANCER BIOLOGY & THERAPY (2016)
The therapeutic potential of natural killer cells to target medulloblastoma
Antonio Perez-Martinez et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays
Hui Li et al.
RADIOLOGY (2016)
Treatment implications of posterior fossa ependymoma subgroups
Vijay Ramaswamy et al.
CHINESE JOURNAL OF CANCER (2016)
Cytogenetic Prognostication Within Medulloblastoma Subgroups
David J. H. Shih et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Hugo J. W. L. Aerts et al.
NATURE COMMUNICATIONS (2014)
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Aurelie Poli et al.
ONCOTARGET (2013)
In vitro natural killer cell immunotherapy for medulloblastoma
Lucia Fernandez et al.
FRONTIERS IN ONCOLOGY (2013)
Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells
Tony Avril et al.
BRAIN PATHOLOGY (2012)
Radiomics: Extracting more information from medical images using advanced feature analysis
Philippe Lambin et al.
EUROPEAN JOURNAL OF CANCER (2012)
Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With Reirradiation
Eric Bouffet et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy
Sunanda Pejavar et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Challenging issues in pediatric oncology
Ching-Hon Pui et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis
Stergios Zacharoulis et al.
CHILDS NERVOUS SYSTEM (2010)
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
R. G. Grundy et al.
EUROPEAN JOURNAL OF CANCER (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors
Chie-Schin Shih et al.
CANCER (2008)
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma
A. Plonquet et al.
ANNALS OF ONCOLOGY (2007)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Combining multiple clusterings using evidence accumulation
ALN Fred et al.
IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2005)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
分享论文
